First New Malaria Drug in Years Performs Strongly in Late-Stage Testing Novartis said its experimental treatment cured more than 99% of malaria cases in the trial, marking a big step toward approval. Post navigation Previous Previous post: Tech, Media & Telecom Roundup: Market TalkNext Next post: Will the Visa-Mastercard settlement impact your credit card rewards? What to know Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News GTA 6 gets physical editions, but only for its soundtrack 0 King Charles III Urges AI Chiefs to Stop Tech Going Rogue 0
